Vyvanse in Children Aged 6 to 12 Years
NCT05416125
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Obesity, Childhood
Interventions
DRUG:
Lisdexamfetamine Dimesylate
BEHAVIORAL:
Lifestyle therapy
Sponsor
University of Minnesota